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Abstract
Studies have revealed high rates of neurodevelopmental and psychiatric comorbid conditions among individuals
diagnosed with attention-deficit/hyperactivity disorder (ADHD). However, research on this topic in the Arab world
has been limited. This study evaluates the medical, neurodevelopmental, and psychiatric comorbidities in children
and adolescents diagnosed with ADHD in Dubai, United Arab Emirates (UAE). A total of 428 pediatric patients
diagnosed with ADHD were included. Children and adolescents with ADHD had high rates of comorbid disorders.
Twenty comorbid conditions were identified. More than 3 quarters of the study sample had at least 1 comorbid
disorder. The most common comorbidity among children was autism spectrum disorder, and among adolescents was
anxiety disorders. Comprehensive assessments are highly warranted to identify and manage associated comorbid
conditions. Further research is needed in exploring the biopsychosocial factors contributing to the elevated rate of
comorbidity in children and adolescents with ADHD.
Keywords
attention-deficit/hyperactivity disorder, children, adolescents, Dubai, United Arab Emirates, comorbidities,
neurodevelopmental disorder
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one
of the most common neurodevelopmental disorders.
According to a meta-analysis of 175 studies, the worldwide prevalence of ADHD is estimated to be around
7%.1 A systematic review of the epidemiology of ADHD
in 22 Arab countries revealed comparable rates. For
instance, the prevalence of ADHD, predominantly hyperactive presentation was 1.4% to 7.8%, and the prevalence
of ADHD, predominantly inattentive presentation was
2.1% to 2.7%.2 A study exploring the rate of ADHD
among school-age children and adolescents in the United
Arab Emirates (UAE) revealed significant Conners rating scale scores among 4.1% as per parents’ report and
among 3.4% as per teachers’ report.3

Presence of comorbid conditions in children and adolescents diagnosed with ADHD is very common.
According to a study, which included 1919 individuals
diagnosed with ADHD, about two-thirds had at least one
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comorbid neurodevelopmental or psychiatric disorder.4
Learning difficulties are commonly present among children with ADHD.5 Studies have revealed that rates of
grade repetitions, and poor academic performance are
more frequent in this population.5 Studies in the Arab
region revealed high rates of comorbidity. For instance,
mood disorders were present in nearly one fifth of the
sample, and anxiety disorders were present in about one
sixth.6
Higher severity of symptoms, as well as ADHD
combined presentation were associated with higher
rates of comorbidity.4 Co-occurring anxiety or mood
disorders have been resulting in more impairment in
psychosocial functioning.5 Children with ADHD along
with an anxiety disorder or a depressive disorder had
tenfold risk of poor academic performance compared
with children who only had ADHD.7 Furthermore,
comorbidity with conduct disorder has been associated
with an increased risk for cigarette smoking and substance abuse.8
There are only 2 studies in the Arab region that have
evaluated comorbid conditions in ADHD,6,9 and none in
the United Arab Emirates to date. We have conducted
this study to explore medical, neurodevelopmental, and
psychiatric comorbidities in children and adolescents
diagnosed with ADHD. Data has been analyzed from a
sample that had a comprehensive assessment at Al Jalila
Children’s Specialty Hospital, a tertiary pediatric institution in Dubai, UAE. This study explored the contributing factors that play a role in the development of ADHD
and its comorbidities. Furthermore, it evaluated various
determinants of co-morbidity, and their impact on the
course trajectory of ADHD.

Methods
The current study is an epidemiological/descriptive
study that aimed to explore retrospective data from electronic medical records in a tertiary pediatric hospital in
Dubai, UAE. The study used systematic sampling on a
population of children and adolescents diagnosed with
ADHD at Al Jalila Children’s Specialty Hospital
between the years 2017 to 2020. All the assessments of
the included sample were conducted by qualified child
and adolescent psychiatrists. The diagnoses were based
on clinical assessments as per the Diagnostic Statistical
Manual of Mental Disorders, fifth Edition (DSM-5) criteria.10 For children and adolescents who had comorbid
conditions, for example, autism spectrum disorder, multidisciplinary team (MDT) comprehensive assessments
were conducted in line with recommendations of international guidelines.11
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Participants
The population of interest for this study included children and adolescents aged 4 to 17 years old, who have
been diagnosed with ADHD following an evaluation
at the Mental Health Services at Al Jalila Children’s
Specialty Hospital. The data included in the study was
for all children and adolescents assessed during the
years 2017, 2018, 2019, and 2020 who met the study
criteria. Patients aged less than 4 years old or older
than 18 years old were excluded from the study and
any patient not diagnosed with ADHD were also
excluded.

Materials
A data collection tool generated using Microsoft Excel
obtained various demographic information, which include
age, gender, as well as information relating to diagnoses,
scores of relevant rating scales, birth-related parameters,
and family history of neurodevelopmental disorders.

Procedure
Data was collected through the electronic records at Al
Jalila Children’s Specialty Hospital. To preserve confidentiality and security a de-identified patient database
was compiled. All data was protected through restricted
user-access via login on hospital premises only. The
safety of the data and patient related information was
overseen by the principal investigator who consulted
with the research committee at Al Jalila Children’s for
any concerns or questions.
Ethics approval and consent to participate. No patients
were excluded from this study based on racial, gender,
religious, or cultural backgrounds. Consent was not
required for this study, as it was based on assessing
anonymous archival data. The local ethical review
board, at Dubai Healthcare City Authority (DHCA),
approval was sought before conducting the study under
the IRB approval DHCR/June 2, 2020. Additional ethical approval was gained from the Zayed University
Research Ethics committee.

Analysis
The data collection tool obtained various information
as mentioned above. Statistical Analysis software
package SPSS Version 26 was used to compile descriptive statistics and conduct correlations and paired t-test
analyses.
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Results
Demographics
The total number of medical records was for 497 children and adolescents of whom 428 were diagnosed with
ADHD. The minimum age of the sample was 4 years old
and the maximum was 17 years old (mean = 8.29,
SD = 3.34). The sample included both males and females.
332 (77.6%) patients were male while 96 (22.4%) were
female. The 497 patients represented 37 different nationalities, with Emirati patients evidently comprising the
majority. Emirati patients made up 68.41% (n = 340),
followed by Egyptian patients at 4.83% (n = 24),
Jordanians at 2.62% (n = 13), Indian and British patients
at 2.0% (n = 10), while Yemeni, Saudi, Lebanese, and
American patients accounting for 1.81% (n = 9).

Perinatal Factors
The mean birth weight of the individuals in this study
was 2.7 kg, SD = 0.9. Patient’s mothers mean age = 32.9,
SD = 7.4. Based on the available data, regarding gestational age at delivery, 35 (10.6%) were born premature,
while 296 (89.4%) of the patients were born at full term.
Paternal age mean = 36.2, SD = 8.5). In terms of complications during pregnancy, out of 263 reported information, 39 (14.8%) of the patients’ mothers had Gestational
Diabetes (GD). Out of 273 reported information, 48
(17.6%) of the patients’ mothers had psychosocial stress
during pregnancy. Out of 262 reported information, 4
(1.5%) of the patients’ mother had anxiety during pregnancy. Out of 81 reported information, 13 (5.0%) of the
patients’ mothers had Pre/Post-partum depression (PPD)
during or after pregnancy. Smoking during pregnancy
was reported in 3 (4.2%) of the mothers out of 71 available information. Alcohol consumption during pregnancy was reported by one (1.6%) of the mothers out of
63 available information. One (0.7%) of the patients’
mothers consumed drugs during pregnancy out of the
135 available information.

Comorbidity
The comorbidity rate was high in the study sample.
77% of the patients with ADHD had at least 1 comorbidity, 42% had at least 2 comorbidities, and 20% had at
least 3 comorbid conditions (Figure 1). The top 5
comorbid disorders were autism spectrum disorder
(ASD), learning disorder, sleep problems, language disorder, and anxiety disorders (Table 1). Patients aged 4
to 11 with ADHD (n = 335) had a number of comorbid
conditions namely ASD (n = 83), learning disorder
(n = 68), language disorder (n = 65), sleep problems
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(n = 59), and anxiety (n = 48) (Table 2). Patients with
ADHD aged 12 and above (n = 70) had a number of
comorbid conditions namely Anxiety (n = 24), learning
disorder (n = 22), sleep problems (n = 21), ASD (n = 14),
and intellectual disability (n = 13) (Table 3).

Family History of Patients With ADHD
Twenty-two (6.3%) of the patients, out of 351 patients
with available information, had family history of ADHD
in first degree relatives. Thirty-four (9.9%) of the
patients, out of 345 patients with available information,
had a family history of ADHD in second degree relatives. Family history of ASD in first degree relatives was
reported in 11 (3.2%), out of 344 patients with available
information. Family history of ASD in second degree
relatives was reported in 46 (13.4%) out of 344 patients
with available information. Family history of anxiety
disorders in first degree relatives was reported in 19
(5.7%), out of 335 patients with available information.
Family history of anxiety disorders in second degree
relatives was reported in 9 (2.7%), out of 334 patients
with available information.

Gender and Diagnosis
A chi-square test of independence was performed to
examine the relation between gender and ADHD.
Females compromised 96 (22%) and males 332 (78%)
of the total sample of 428 children and adolescents. The
relationship between these variables was not significant
χ2 (1, N = 497) = 0.16, P = .89. In the 332 male children
and adolescents with ADHD, 91 patients had comorbid
ASD, 66 had sleep problems, 63 had language disorder,
63 had learning disorders, 54 had anxiety disorders, 25
had intellectual disability, and 22 had epilepsy. In the 96
female children and adolescents with ADHD, 28 had
comorbid learning disorders, 21 with sleep problems, 18
had anxiety disorders, 17 had language disorders, 15 had
intellectual disability, 14 had ASD, and 9 had epilepsy.

Correlational Analysis for Age and ADHD
Symptomatology
The severity of symptoms as assessed by the Vanderbilt
scale at baseline in 151 patients with ADHD, age 4 to
11 years, as reported by parents revealed a mean score of
5.7 (SD = 2.6) for inattentive symptoms, and a mean
score of 5.9 (SD = 2.8) for hyperactive/impulsive symptoms. In 105 children, the same scale reported by teachers showed a mean score of 5.1 (SD = 2.5) for inattentive
symptoms and a mean score of 4.4 (SD = 2.9) for hyperactive/impulsive symptoms (Table 4).
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Figure 1. Number of Comorbid disorders with ADHD.
Table 1. Comorbid Disorders With ADHD in the Study Sample.
Descriptive statistics (n = 428)

Autism spectrum disorder
Intellectual disability
Language disorder
Motor disorder
Anxiety
Learning disorder
Depressive disorder
Oppositional defiant disorder
Conduct disorder
Obsessive compulsive disorder
Post-traumatic stress disorder
Tic disorder
Sleep problems
Sleep disorder
Fragile-X syndrome
Epilepsy

Sum

Mean

Std.
deviation

105
40
80
8
72
91
7
38
10
8
6
12
86
15
4
31

0.25
0.09
0.19
0.02
0.17
0.21
0.02
0.09
0.02
0.02
0.01
0.03
0.20
0.04
0.01
0.07

0.43
0.29
0.39
0.14
0.38
0.41
0.13
0.29
0.15
0.14
0.12
0.17
0.40
0.18
0.10
0.26
(continued)
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Table 1. (continued)
Descriptive statistics (n = 428)

Asthma
Enuresis
Substance abuse disorder
Suicide
Bipolar disorder
Schizophrenia
Eating disorder

Sum

Mean

Std.
deviation

19
22
1
0
1
0
6

0.04
0.05
0
0
0
0
0.01

0.21
0.22
0.05
0
0.05
0
0.12

Sum

Mean

Std.
deviation

83
26
65
8
48
68
3
29
9
3
2
9
59
10
3
25
16
18
0
0
0
0
5

0.25
0.08
0.19
0.02
0.14
0.20
0.01
0.09
0.03
0.01
0.01
0.03
0.18
0.03
0.01
0.07
0.05
0.05
0
0
0
0
0.01

0.43
0.27
0.40
0.15
0.35
0.40
0.09
0.28
0.16
0.09
0.08
0.16
0.38
0.17
0.09
0.26
0.21
0.23
0
0
0
0
0.12

Sum

Mean

Std.
deviation

14
13
8
0

0.20
0.19
0.11
0

0.40
0.39
0.32
0

Table 2. Comorbid Disorders With ADHD Ages 4 to 11 Years.
Descriptive statistics (n = 335)

Autism spectrum disorder
Intellectual disability
Language disorder
Motor disorder
Anxiety
Learning disorder
Depressive disorder
Oppositional defiant disorder
Conduct disorder
Obsessive compulsive disorder
Post-traumatic stress disorder
Tic disorder
Sleep problems
Sleep disorder
Fragile-X syndrome
Epilepsy
Asthma
Enuresis
Substance abuse disorder
Suicide
Bipolar disorder
Schizophrenia
Eating disorder

Table 3. Comorbid Disorders With ADHD Age 12 Years and Above.
Descriptive statistics (n = 70)

Autism spectrum disorder
Intellectual disability
Language disorder
Motor disorder

(continued)
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Table 3. (continued)
Descriptive statistics (n = 70)

Anxiety
Learning disorder
Depressive disorder
Oppositional defiant disorder
Conduct disorder
Obsessive compulsive disorder
Post-traumatic stress disorder
Tic disorder
Sleep problems
Sleep disorder
Fragile-X syndrome
Epilepsy
Asthma
Enuresis
Substance abuse disorder
Suicide
Bipolar disorder
Schizophrenia
Eating disorder

Sum

Mean

Std.
deviation

24
22
4
9
1
5
4
2
21
3
1
2
2
4
1
0
1
0
0

0.34
0.31
0.06
0.13
0.01
0.07
0.06
0.03
0.30
0.04
0.01
0.03
0.03
0.06
0.01
0
0.01
0
0

0.48
0.47
0.23
0.34
0.12
0.60
0.23
0.17
0.46
0.12
0.17
0.17
0.17
0.23
0.12
0
0.12
0
0

Table 4. Mean Scores for the Baseline Vanderbilt Scale for Patients With ADHD Age 4 to 11 Years.
Descriptive statistics

Vanderbilt Parent Inattentive Score (Baseline) n = 151
Vanderbilt Parent Hyperactive/impulsive (Baseline) n = 151
Vanderbilt Teacher Inattentive Score (Baseline) n = 105
Vanderbilt Teacher Hyperactive/impulsive (Baseline) n = 105

Among adolescents, age 12 to 17 years, with ADHD.
Only 34 adolescents had the Vanderbilt rating scale parent version, inattentive domain, completed, and 33 had
the Vanderbilt rating scale parent version, hyperactive/
impulsive domain, completed. The mean score for inattentive symptoms reported by parents was 6.1 (SD = 2.4)
and for hyperactive/impulsive symptoms was 4.5
(SD = 3). Only 19 adolescents had the Vanderbilt rating
scale teacher version, inattentive domain, completed,
and 18 had the Vanderbilt rating scale teacher version,
hyperactive/impulsive domain, completed. The mean
score for inattentive symptoms reported by teachers was
4.7 (SD = 2.7) and for hyperactive/impulsive symptoms
was 4.1 (SD = 2.6) (Table 5). Although the mean score of
hyperactive/impulsive symptoms reported by parents as
well as teachers was lower among the adolescent group

Mean

Std.
deviation

5.72
5.90
5.08
4.40

2.56
2.81
2.48
2.86

in comparison to the children group, it is hard to draw a
conclusion given that we did not have an adequate number of Vanderbilt scale follow up scores.

Follow Up Analysis of Symptoms Among
Patients With ADHD
A negative correlation was found between Vanderbilt
parent scale hyperactive/impulsive domain scores at
baseline with age r(191) = −.200, P = .005) and Vanderbilt
teacher hyperactive/impulsive domain scores at baseline
with age r(126) = −.200, P = .002). Vanderbilt scale
hyperactive/impulsive domain scores declined over time.
When following a subsample of patients, with available data, from baseline to follow up at 3 months we
found Vanderbilt, hyperactive/impulsive domain, scores
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Table 5. Mean Scores for the Baseline Vanderbilt Scale for Patients With ADHD Age 12 to 17 Years.
Descriptive statistics

Vanderbilt Parent Inattentive Score (Baseline) n = 34
Vanderbilt Parent Hyperactive/impulsive (Baseline) n = 33
Vanderbilt Teacher Inattentive Score (Baseline) n = 19
Vanderbilt Teacher Hyperactive/impulsive (Baseline) n = 18

decline on follow up at 3 months. This was based on a
paired t-test that was conducted for both the Vanderbilt
parent hyperactive/impulsive domain scale t(26) = .258,
P = .016) n = 27; and the Vanderbilt teacher hyperactive/
impulsive domain scale t(14) = .239, P = .031) n = 15.

Discussion
This is the first study in the UAE to examine children and
adolescents with ADHD and the rates of comorbidity. The
database used in the study was from a sample of patients
assessed at a tertiary pediatric hospital. Our key findings
reveal that in a sample of 428 pediatric population with
ADHD, 77% had 1 or more comorbid disorder, 42% had
2 or more comorbid disorders, and 20% had 3 or more
comorbid disorders. The top 5 comorbid disorders were
autism spectrum disorder (ASD), learning disorder, sleep
problems, language disorder, and anxiety disorders.
Our sample consisted of 332 males and 96 females.
Chi square results revealed proportions in our sample of
patients with ADHD did not differ between males and
females. For the top 5 comorbidities we found gender differences in proportions of ASD and learning disorders.
The results from a correlational analysis indicated
ADHD symptoms of hyperactivity/impulsivity consistently decrease with age. Also, in a subsample from
baseline to 3 month follow up we observed decreased
hyperactive symptoms which may be indicative of treatment response. We ran a preliminary analysis examining
ADHD symptomatology as measured by the Vanderbilt
Parent Version (n = 191) and Teacher Version (n = 126)
Scales on a subsample.

Rate of Comorbid Disorders
The findings of this study revealed high rates of comorbid neurodevelopmental and psychiatric disorders
among children diagnosed with ADHD. Twenty cooccurring disorders were reported in this study.
Comorbidity with neurodevelopmental disorders, for
instance ASD, learning disorders, and language disorder, was noted to be higher than other conditions.

Mean

Std.
deviation

6.17
4.48
4.68
4.05

2.41
3.01
2.72
2.60

The overlap between ADHD, externalizing (eg,
oppositional defiant disorder or conduct disorder) and
internalizing disorders (eg, anxiety disorders or mood
disorders) has been reported in multiple studies.7,12-14
Furthermore, research has highlighted elevated comorbidity rate among neurodevelopmental disorders, for
instance ADHD with learning disorders or autism spectrum disorder.12,13,15-17
Various hypotheses have been proposed to explain
comorbidity in ADHD: (1) comorbid disorders are phenotypic variabilities of ADHD rather than representing
distinct disorders, (2) each comorbidity represents a
separate disorder, (3) comorbid disorders share common
risk factors, (4) comorbid disorders represent distinct
subtypes within ADHD, (5) ADHD is an early manifestation of the comorbid disorder, (6) ADHD increases the
risk for the development of the comorbid disorder.12

Effect of Age on Symptoms and Rate of
Comorbid Disorders
This study has shown that the severity of hyperactive/
impulsive symptoms was lower among adolescents in
comparison to children. However, it was difficult to
determine an age-related association with severity of
symptoms since adequate longitudinal data was lacking.
Among children aged 4 to 11 years in the study sample
ASD, learning disorder, language disorder, sleep problems and anxiety disorders were the most common
comorbidities. However, in adolescents aged 12 to
17 years most common comorbidities were anxiety disorders, followed by learning disorder, sleep problems,
ASD and intellectual disability.
A previous study evaluating 811 children and adolescents with ADHD revealed similarities in both age
groups, that is, children versus adolescents, in terms of
the mean number of ADHD symptoms.18 However,
some differences were noted in regards to the rate of
comorbid conditions. For instance, major depression
was present in 30% of the adolescents’ sample, in comparison to 25% of the children’s sample.18 The rate of
conduct disorder was 23% among adolescents and 15%
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among children.18 The rate of anxiety disorders was
more similar among the 2 groups as it was 59% among
adolescents and 62% among children.18 Longitudinal
studies have suggested that persistence of symptoms
into adulthood occurs in around two-thirds of individuals diagnosed with ADHD.19
A study assessing the effects of age on functional
impairment among 416 children and adolescents
revealed greater homework problems in the adolescents’
group.20 This difference was attributed to the increase in
academic demands as students progress in school.20

Effect of Gender on Symptoms and Rate of
Comorbid Disorders
The majority of the study sample were male children
and adolescents (78%). The rate of comorbid conditions
was different, for instance 27% of the male sample had
ASD while only 15% of the female sample had ASD.
While 16% of the male sample had an anxiety disorder
and 19% of the female sample had an anxiety disorder.
Although gender did not moderate associations
between comorbid symptoms and sleep problems, there
is evidence that girls with ADHD experience more sleep
problems than boys with ADHD.21 Although our study
did not find a significant association between gender
and ADHD diagnosis, sleep problems were identified in
a higher proportion amongst females (21.9%) than their
male counterparts (19.9%). This goes in-line with existing studies on gender and sleep problems, as discussed
above.
Correlations between ADHD subtypes and comorbid
conditions within genders were noted in a study evaluating 1896 children.22 In children diagnosed with the combined subtype of ADHD, boys were more likely to be
comorbid with mood disorders than girls.22 For those
diagnosed with the inattentive type, girls were more
likely to be comorbid with anxiety disorders than boys.22
In our study sample, females (18.8%) represented a
higher proportion of anxiety disorders as an ADHD
comorbidity than their male counterparts (16.3%).

Potential Pre- and Perinatal Risk Factors
This study has evaluated a variety of potential pre- and
perinatal risk factors, for instance family history of neurodevelopmental disorders, weight at birth, premature
delivery, gestational diabetes, maternal smoking, psychosocial stressors during pregnancy.
Studies have shown a heritability link associated with
ADHD of up to 80%,23 with the potential of detection as
early as the first 2 years of life.24 In a study by Starck
et al25 assessing both parents and children with ADHD,
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ADHD occurrence for mothers of children with ADHD
was 41.3%, 51.0% for fathers. No significant correlation
between parental and child diagnoses was found.25
Beyond the genetic link, there is considerable interest
in the role that the prenatal environment might play in
the development of ADHD. This is highlighted through
various studies that looked into associations between
prenatal risk factors (eg, prematurity, gestational age,
birth weight, maternal smoking during pregnancy) and
ADHD.26-28
Henriksen et al29 conducted a nationwide cohort
study of live singleton birth after spontaneous onset of
labor (N = 546 146) of which 4617 had a diagnosis of
ADHD, further supporting the association between prematurity and ADHD.
Studies by Halmøy et al,28 Henriksen et al,29 and Silva
et al,30 all concluded that low birth weight conferred risk
for ADHD in unadjusted analyses. On the contrary,
Nawaz and Sultan17 found no significant association
between low birthweight and ADHD, and instead found a
statistical correlation with high birth weight and ADHD.
Two of these studies reported that children who are
born small for gestational age (SGA) were at an
increased risk for getting diagnosed with ADHD.28-30
Similar findings were observed in a large-scale study of
113 227 children where those born early preterm were
rated with more symptoms of ADHD, inattention, and
hyperactivity/impulsivity than term-born children.31
Langley et al32 demonstrated that both maternal and
paternal smoking during pregnancy was associated with
increased parent-reported ADHD symptoms. Recent
studies on the topic of maternal substance abuse during
pregnancy and ADHD diagnosis were not identified,
there is a need for further investigation on this plausible
relationship.
Strengths and limitations. Strengths of this study include
the large sample size as well as data being collected
from encounters over a 4-year period. Furthermore, it
explored multiple variables that may impact comorbidity rate. Limitations of this study include missing data
on some variables related to risk factors as well as missing scores of follow up rating scales. The reason for the
missing data is not clear. If these information were available they could have contributed to a more in depth
understanding of biopsychosocial contributing factors to
the development of comorbidity as well as their impact
on the trajectory of symptoms. Additionally, the limitation in reporting family history of neurodevelopmental
and psychiatric disorders may be in the context of lack
of resources in the past.
Furthermore, the gender distribution in the study
sample resulted in a relatively small total number of
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females, which impacted the ability to explore significant differences in clinical presentation. Although data
was collected from the only child and adolescent mental
health center of excellence in the UAE, participants
were not recruited from nationwide population
sampling.
Implications. Elevated rate of comorbid neurodevelopmental and psychiatric disorders in children with ADHD
have been highlighted in this study. Previous studies
have indicated that presence of comorbid conditions in
individuals with ADHD has resulted in significant
impairment in academic performance.7,20,33,34 Additionally, an increase in stress levels in the family household
has been reported.34 Longitudinal research has also
shown that presence of comorbidity predicts persistence
of ADHD symptoms.35
These findings highlight the importance of education
and awareness among parents, teachers and healthcare
professionals. This includes the importance of seeking
comprehensive clinical assessments. Additionally, early
evidence-based interventions for ADHD symptoms
and comorbid disorders are highly recommended.
Accommodation at school will contribute to children
with ADHD achieving their highest potential.
Furthermore, assessment of stress level among parents
and family members will assist in allocation of appropriate support services.
Future research recommendations. The development of
ADHD has been associated with various contributing
factors including demographics, genetics and co-morbidities as explored by our study. Our findings of early
age of onset, male preponderance and strong comorbidity association with other childhood neurodevelopmental disorders supports the inclusion of ADHD as part of
the neurodevelopmental group of disorders in the DSM5. Due to the multifactorial nature underlying the etiology of ADHD, it is vital that we have a multidisciplinary
and integrated approach for treating children and adolescents with ADHD.36 In line, there should be more
research done that explores the neuropsychiatric pathophysiology of ADHD. This could include looking at
various medical diagnostic parameters such as electroencephalography, brain imaging or other biological
markers.
Given the genetic component behind ADHD, research
involving genomic sequencing and analysis is now progressing via large scale collaborations. This could have
essential clinical implications as it could potentially lead
to early detection, and precision-based management. A
pertinent area of future research that is worth exploring
is how treatment of parent ADHD might impact on child
ADHD features and comorbidity. This would help us get
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a deeper understanding of the etiology of ADHD, if it’s
mainly due to environmental or genetic factors.

Conclusion
Similar to findings of international research, this study
has revealed a high rate of comorbidities in children and
adolescents diagnosed with ADHD in the UAE. The
results showed that the most common comorbidities
were ASD, learning disorder, and language disorder,
which highlights the significant overlap between neurodevelopmental disorders. Furthermore, more than 40%
of the children and adolescents with ADHD in this study
had at least 2 additional comorbid disorders.
Further research is needed in this field to explore the
biopsychosocial factors contributing to the elevated rate
of comorbidity in children and adolescents with ADHD.
In the context of contribution of comorbidity to marked
impairment in functioning, comprehensive assessments
are highly warranted to identify and manage any associated conditions.
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